Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
16.01
+0.02 (0.13%)
At close: May 28, 2025, 4:00 PM
16.07
+0.06 (0.37%)
After-hours: May 28, 2025, 4:04 PM EDT

Enliven Therapeutics Market Cap

Enliven Therapeutics has a market cap or net worth of $785.60 million as of May 28, 2025. Its market cap has decreased by -29.77% in one year.

Market Cap
785.60M
Enterprise Value
502.60M
1-Year Change
-29.77%
Ranking
Category
Stock Price
$16.01

Market Cap Chart

Since February 24, 2023, Enliven Therapeutics's market cap has decreased from $974.02M to $785.60M, a decrease of -19.34%. That is a compound annual growth rate of -9.09%.

History

DateMarket Cap% Change
May 27, 2025784.62M-28.63%
Dec 31, 20241.10B92.74%
Dec 29, 2023570.37M-41.44%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 640.72B
Johnson & Johnson 367.98B
AbbVie 323.71B
Novo Nordisk 298.78B
UnitedHealth Group 268.12B
Abbott Laboratories 228.44B
Novartis AG 221.01B
AstraZeneca 218.42B
Market Cap Rankings